Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rhea N Coler

Showing results (101-110 of 132) with videos related to

Pageof 14
Sort By:
Vaccine|September 21, 2010
A clinical trial to evaluate the safety and immunogenicity of the LEISH-F1+MPL-SE vaccine when used in combination with sodium stibogluconate for the treatment of mucosal leishmaniasisAlejandro Llanos-Cuentas, Wessmark Calderón, María Cruz, et al.
Medrxiv : the Preprint Server for Health Sciences|October 7, 2022
Spike-specific T cells are enriched in breastmilk following SARS-CoV-2 mRNA vaccinationBlair Armistead, Yonghou Jiang, Marc Carlson, et al.
Plos Neglected Tropical Diseases|November 28, 2017
Pre-clinical antigenicity studies of an innovative multivalent vaccine for human visceral leishmaniasisPedro Cecílio, Begoña Pérez-Cabezas, Laura Fernández, et al.
Vaccine|August 7, 2010
A clinical trial to evaluate the safety and immunogenicity of the LEISH-F1+MPL-SE vaccine when used in combination with meglumine antimoniate for the treatment of cutaneous leishmaniasisEvaldo Nascimento, Demetrios F Fernandes, Edva P Vieira, et al.
Scientific Reports|January 22, 2016
Different human vaccine adjuvants promote distinct antigen-independent immunological signatures tailored to different pathogensNiels Peter H Knudsen, Anja Olsen, Cecilia Buonsanti, et al.
Mucosal Immunology|January 15, 2023
Spike-specific T cells are enriched in breastmilk following SARS-CoV-2 mRNA vaccinationBlair Armistead, Yonghou Jiang, Marc Carlson, et al.
Virology Journal|January 20, 2025
Evaluation of host immune responses to Mycobacteriophage Fionnbharth by route of deliveryThomas Smytheman, Tiffany Pecor, Dana E Miller, et al.
Plos One|November 10, 2010
A synthetic adjuvant to enhance and expand immune responses to influenza vaccinesRhea N Coler, Susan L Baldwin, Narek Shaverdian, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|August 7, 2018
A Nanostructured Lipid Carrier for Delivery of a Replicating Viral RNA Provides Single, Low-Dose Protection against ZikaJesse H Erasmus, Amit P Khandhar, Jeff Guderian, et al.
Vaccine|May 5, 2016
Strategic evaluation of vaccine candidate antigens for the prevention of Visceral LeishmaniasisMalcolm S Duthie, Michelle Favila, Kimberley A Hofmeyer, et al.
Pageof 14

Showing results (101-110 of 132) with videos related to

Sort By:
Pageof 14
Vaccine|September 21, 2010
A clinical trial to evaluate the safety and immunogenicity of the LEISH-F1+MPL-SE vaccine when used in combination with sodium stibogluconate for the treatment of mucosal leishmaniasisAlejandro Llanos-Cuentas, Wessmark Calderón, María Cruz, et al.
Medrxiv : the Preprint Server for Health Sciences|October 7, 2022
Spike-specific T cells are enriched in breastmilk following SARS-CoV-2 mRNA vaccinationBlair Armistead, Yonghou Jiang, Marc Carlson, et al.
Plos Neglected Tropical Diseases|November 28, 2017
Pre-clinical antigenicity studies of an innovative multivalent vaccine for human visceral leishmaniasisPedro Cecílio, Begoña Pérez-Cabezas, Laura Fernández, et al.
Vaccine|August 7, 2010
A clinical trial to evaluate the safety and immunogenicity of the LEISH-F1+MPL-SE vaccine when used in combination with meglumine antimoniate for the treatment of cutaneous leishmaniasisEvaldo Nascimento, Demetrios F Fernandes, Edva P Vieira, et al.
Scientific Reports|January 22, 2016
Different human vaccine adjuvants promote distinct antigen-independent immunological signatures tailored to different pathogensNiels Peter H Knudsen, Anja Olsen, Cecilia Buonsanti, et al.
Mucosal Immunology|January 15, 2023
Spike-specific T cells are enriched in breastmilk following SARS-CoV-2 mRNA vaccinationBlair Armistead, Yonghou Jiang, Marc Carlson, et al.
Virology Journal|January 20, 2025
Evaluation of host immune responses to Mycobacteriophage Fionnbharth by route of deliveryThomas Smytheman, Tiffany Pecor, Dana E Miller, et al.
Plos One|November 10, 2010
A synthetic adjuvant to enhance and expand immune responses to influenza vaccinesRhea N Coler, Susan L Baldwin, Narek Shaverdian, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|August 7, 2018
A Nanostructured Lipid Carrier for Delivery of a Replicating Viral RNA Provides Single, Low-Dose Protection against ZikaJesse H Erasmus, Amit P Khandhar, Jeff Guderian, et al.
Vaccine|May 5, 2016
Strategic evaluation of vaccine candidate antigens for the prevention of Visceral LeishmaniasisMalcolm S Duthie, Michelle Favila, Kimberley A Hofmeyer, et al.
Pageof 14